Status:
UNKNOWN
Building Evidence-Based Supports for Teens Via Technology
Lead Sponsor:
Stony Brook University
Collaborating Sponsors:
Limbix Health, Inc.
Conditions:
Depression
Eligibility:
All Genders
12-16 years
Phase:
NA
Brief Summary
Major depression (MD) is the leading cause of disability in youth, with a global economic burden of \>$210 billion annually. However, up to 70% of youth with MD do not receive services. Even among tho...
Detailed Description
Psychiatric disorders are the leading cause of disability worldwide, and 40.5% of this burden is attributable to major depression (MD). Rates of MD increase markedly in adolescence, with nearly 20% of...
Eligibility Criteria
Inclusion
- Youth is between the ages of 12-16 years (inclusive) at the time of study enrollment
- Youth has one parent or legal guardian willing to participate in the study (i.e., to be present for the lab visit and to complete questionnaires throughout the study period)
- Youth speaks English well enough to complete online or virtual reality-based intervention activities, which are available in English only
- Indication of elevated risk for youth depression. This criterion may be met in one of two ways (or both ways): (a) The adolescent exhibits elevations in depressive symptoms (subclinical or greater symptom elevations, corresponding to 80th percentile or higher, based on parent-report CDI 2 conducted an initial phone screen); (b) The adolescent received treatment for depression within the previous 2 years (depression tends to recur, so past treatment receipt indicates elevated risk). Past treatment receipt will be assessed via parent report at the time of the phone screen.
Exclusion
- Intellectual disability, as this may undermine comprehension of intervention materials
- Adolescent is non-English speaking, as the virtual reality and online interventions are available in English only;
- Adolescent was hospitalized or received residential/inpatient treatment for suicide attempt or self-harming behaviors within the past 2 months, as the interventions being tested in this study are not designed for adolescents with acute medical and/or psychiatric treatment needs
Key Trial Info
Start Date :
March 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT03858881
Start Date
March 20 2019
End Date
December 30 2021
Last Update
May 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stony Brook University
Stony Brook, New York, United States, 11794-2500